Related Experiment Videos
Dilated cardiomyopathy--new insights into the pathogenesis
H J Why1, L C Archard, P J Richardson
1Department of Cardiology, King's College Hospital, London, UK.
Insights
Viral infections are increasingly linked to dilated cardiomyopathy, a serious heart condition. Understanding this viral heart disease link may lead to new treatments and improved patient outcomes.
Area of Science:
- Cardiology
- Virology
- Pathogenesis
Background:
- Dilated cardiomyopathy (DCM) has a poor prognosis with high morbidity and mortality.
- A viral aetiology is increasingly suspected in DCM patients.
- Viral heart disease is not yet classified by WHO/ISFC.
Purpose of the Study:
- To explore the role of viral infections in dilated cardiomyopathy.
- To understand the impact of viruses on DCM prognosis.
- To identify potential therapeutic targets for viral-induced heart disease.
Main Methods:
- Review of current evidence on viral aetiology in DCM.
- Analysis of the impact of viral infections on DCM pathogenesis.
- Examination of prognostic factors in viral cardiomyopathy.
Main Results:
- Growing evidence supports a viral cause for many DCM cases.
- Viruses significantly influence the prognosis of dilated cardiomyopathy.
- Current classifications do not recognize viral heart disease.
Conclusions:
- Viral infections are a significant factor in dilated cardiomyopathy.
- Further research into viral pathogenesis is crucial for DCM.
- New treatments targeting viral mechanisms could improve DCM outcomes.
Abstract:
There is increasing evidence for a viral aetiology in many patients with dilated cardiomyopathy, although the term viral heart disease is not currently recognized in the WHO/ISFC classification of the cardiomyopathies. The prognosis of dilated cardiomyopathy remains poor with a high morbidity and mortality. New insights into the pathogenesis of dilated cardiomyopathy and the effect of viruses on its prognosis, offer potential for future treatments to modify the natural history of the disease.